First Oral Therapy for Thalassemia Anemia Approved by US FDA

The US FDA has approved Mitapivat (Aqvesme), the first oral treatment for anemia in adults with alpha or beta thalassemia. This breakthrough could reduce transfusion dependence, offering new hope for high-burden countries like India. Read more.

Down Syndrome Kidney Risks: 29% Face AKI by Age 20

A landmark Danish study finds individuals with Down syndrome face significantly higher risks of acute and chronic kidney disease, urging early screening and proactive care for better health outcomes.

Bhopal Slum's Water Crisis: Conflicting Test Results

In Bhopal's Gond Basti, drinking water pipes run under sewage lanes. While one lab report found dangerous contamination, BMC later declared water safe. Residents face health risks daily. Read the full investigation.

Page 670 of 847
Pickt mobile sticky banner — logo, tagline and CTA button